Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

February 23, 2015February 23, 2015

Standardized Packaging Of Tobacco Products May Reduce Smoking, Especially Among the Youth

News

A collection of research papers and commentaries, peer-reviewed, were published in the journal Addiction under the title “Plain Packaging: Weighing up the evidence on standardized packaging for tobacco products” to reaffirm key parts of the ... Read more

February 20, 2015November 6, 2015

US Court Invalidates Patent for AstraZeneca Asthma Drug

Asthma, News

A federal judge in the United States decided last Friday that AstraZeneca PLC‘s patent regarding its Pulmicort Repsules treatment to address asthma was invalid; the market is now open to a second, cheaper ... Read more

February 16, 2015November 5, 2015

New Survey Explores Emotional And Physical Impact of IPF

Idiopathic Pulmonary Fibrosis, News

Those who live with idiopathic pulmonary fibrosis (IPF) often lack knowledge and understanding of their condition, and they tend to experience a heavy emotional burden that makes them feel that more support ... Read more

February 16, 2015February 18, 2015

MediciNova Announces FDA Clearance for Phase 2 Trial Of MN-001 In IPF

News

MediciNova, Inc., a biopharmaceutical company, recently announced that the FDA (U.S. Food and Drug Administration) has approved thecompany’s protocol for a MN-001 (tipelukast) clinical trial to address moderate to severe idiopathic pulmonary fibrosis (IPF). Supported ... Read more

February 13, 2015November 9, 2015

Makrolon® Polycarbonate From Bayer MaterialScience Leads to Lighter, Smaller Ventilator

COPD, News

Those who suffer with respiratory conditions face severe obstacles in performing even the most mundane tasks, such as not being able to climb stairs without stopping to rest or do the dishes. Ventilators ... Read more

February 11, 2015November 9, 2015

AstraZeneca Acquires Rights To Actavis’ Branded COPD Portfolio in Canada and US

COPD, News

Actavis and AstraZeneca have recently announced signing a new agreement assuring that AstraZeneca will acquire the rights to Actavis’ respiratory portfolio in both Canada and the United States for an upfront payment worth $600 million upon completion, ... Read more

February 10, 2015November 9, 2015

National “Program In Lung Healing” To Address Acute Lung Disease Announced By University Of Maryland

COPD, News

The new “Program in Lung Healing” was recently announced by E. Albert Reece, Dean and representative of the University of Maryland School of Medicine (UM SOM) and Jeffrey A. Rivest, CEO and president of the University of ... Read more

February 9, 2015November 9, 2015

Novartis’ Ultibro Breezhaler For COPD Now Available In Quebec

COPD, News

After being recently launched in the UK, the Ultibro® Breezhaler® has been added to the list of medications recognized by the Régie de l’assurance malady du Québec (RAMQ) as a “Médicament d’exception,” and is ... Read more

February 9, 2015October 28, 2015

Medicare To Begin Including CT Scans for Lung Cancer In Coverage

Lung Cancer, News

Medicare has recently decided to include the computed tomography (CT) component in lung cancer screening in its health coverage — a decision that could greatly improve access to lung cancer-related care among seniors deemed high-risk for ... Read more

February 4, 2015November 6, 2015

Corbus Pharmaceuticals To Present on SSc, CF Therapy at 17th Annual BIO CEO & Investor Conference in February

News, Scleroderma

Corbus Pharmaceuticals Holdings, Inc., an emerging drug development company working on the advancement and marketing of its lead product candidate Resunab to address life-threatening and rare fibrotic and inflammatory diseases, announced recently that it ... Read more